cenicriviroc
Sign in to saveAlso known as TAK 652, TAK-652, TAK652
Cenicriviroc (INN, code names TAK-652, TBR-652, commonly abbreviated as CVC) is an experimental drug candidate for the treatment of HIV infection and in combination with Tropifexor for non-alcoholic steatohepatitis. It is being developed by Takeda and Tobira Therapeutics.
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 696.370927
- Has use
- medication
Show 4 more facts
- chemical formula
- C₄₁H₅₂N₄O₄S
- isomeric SMILES
- CCCCOCCOC1=CC=C(C=C1)C2=CC/3=C(C=C2)N(CCC/C(=C3)/C(=O)NC4=CC=C(C=C4)[S@@](=O)CC5=CN=CN5CCC)CC(C)C
- canonical SMILES
- CCCCOCCOC1=CC=C(C=C1)C2=CC3=C(C=C2)N(CCCC(=C3)C(=O)NC4=CC=C(C=C4)S(=O)CC5=CN=CN5CCC)CC(C)C
- physically interacts with
- C-C motif chemokine receptor 5
Sources (2)
via Wikidata · CC0
~3 min read
Encyclopedic overview
2 sectionsContents
- See also
- References
{{Chembox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 451756573 | ImageFile = Cenicriviroc.svg | ImageClass = skin-invert-image | ImageSize = 315px | ImageAlt = | PIN = (5E)-8-[4-(2-Butoxyethoxy)phenyl]-1-(2-methylpropyl)-N-{4-[(S)-(1-propyl-1H-imidazol-5-yl)methanesulfinyl]phenyl}-1,2,3,4-tetrahydro-1-benzazocine-5-carboxamide | OtherNames = TAK-652; TBR-652
| Section1 =
Excerpted from Wikipedia’s “cenicriviroc” article, available under the CC BY-SA 4.0 licence.